Sheila Mikhail is the founder of Asklepios BioPharmaceutical. Asklepios BioPharmaceutical has raised $235M in total funding. Latest round: Series A.
Sheila Mikhail is the Co-founder and CEO of Asklepios BioPharmaceutical (AskBio), a biotechnology company specializing in gene therapy. She led AskBio to secure $235 million in Series A funding and orchestrated its $4 billion acquisition by Bayer AG. Mikhail has been recognized as one of the 'Fiercest Women in Life Sciences' and received the Entrepreneurial Award from the University of Chicago Booth School of Business.
Full founder directory · Investor directory · Company funding database · Fundraising library